Colgate-Palmolive (CL) FY2025 10-K Annual Report
Colgate-Palmolive (CL) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 23, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Colgate-Palmolive FY2025 10-K Analysis
Business Overview
- • Two-segment model: Oral/Personal/Home Care (77% combined net sales) and Pet Nutrition (23%), sold in 200+ countries
- • New C-suite hires: Shane Grant (COO Americas, ex-Danone) and John Hazlin (Chief Growth Officer) added in 2025
Management Discussion & Analysis
- • Revenue $20,382 in 2025, up 1.4% YoY; organic sales +1.4% driven by 2.1% net pricing, offset by -0.4% volume and -0.3% FX
- • GAAP operating margin 16.2% vs 21.2% (−500 bps) due to $919 pretax Filorga impairment; non-GAAP operating margin 21.3% vs 21.7% (−40 bps); gross margin 60.1% vs 60.5%
Risk Factors
- • FDA and global regulators reviewing fluoride, titanium dioxide, synthetic colors, and PFAS in consumer products — reformulation or restriction could materially impact core product lines
- • Eurasia operations ~1% of consolidated net sales and ~2% of consolidated operating profit; cash repatriation from Russia blocked and financial institution access constrained
Colgate-Palmolive FY2025 Key Financial MetricsXBRL
Revenue
$20.4B
▲ +1.4% YoY
Net Income
$2.1B
▼ -26.2% YoY
Gross Margin
60.1%
▼ -39bp YoY
Operating Margin
16.2%
▼ -501bp YoY
Net Margin
10.5%
▼ -391bp YoY
ROE
3948.1%
▲ +258541bp YoY
Total Assets
$16.3B
▲ +1.8% YoY
EPS (Diluted)
$2.63
▼ -25.1% YoY
Operating Cash Flow
$4.2B
▲ +2.2% YoY
Source: XBRL data from Colgate-Palmolive FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Colgate-Palmolive
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.